U.S. FDA approves CAPVAXIVE (V116), specifically designed for pneumococcal disease in adults Read more
Alembic Pharma announces USFDA final approval for Icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe Read more
Orchid Pharma receives DCGI approval for its antibiotic drug combination of Cefepime and Enmetazobactam (NCE) Read more
Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications: GlobalData Read more